David P. Kaul
Potsdam, BB 14471, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma.
Journal: Acta neuropathologica communications
Published: April 17, 2026
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy.
Journal: JAMA network open
Published: January 14, 2026
Genomic evolution of high-risk soft tissue sarcomas under thermo- and chemotherapeutic selection pressure.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: November 04, 2025
Comparative Analysis of the Prognostic Value of Simpson Grade Versus MRI-Based Extent of Resection Paradigms Across Meningioma Histomolecular Subgroups.
Journal: Neurosurgery
Published: July 04, 2025
Characteristics of patients with epithelioid hemangioendothelioma (EHE): a retrospective analysis of the Charité- Universitätsmedizin Berlin.
Journal: Journal of cancer research and clinical oncology
Published: May 16, 2025
Correction: The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers.
Journal: Journal of cancer research and clinical oncology
Published: April 24, 2025
Use of radiofrequency electromagnetic fields applied by capacitive hyperthermia for glioblastoma therapy.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: April 21, 2025
The interdisciplinary management of craniopharyngioma - practice patterns, outcomes, and insights.
Journal: BMC cancer
Published: April 17, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytoma.
Journal: Acta neuropathologica
Published: February 28, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis.
Journal: The Lancet. Oncology
Published: January 29, 2025
Last Updated: 09/26/2026